Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease

摘要

BackgroundThe Women’s Health Initiative randomized trial found greater coronary heart disease (CHD) risk in women assigned to estrogen/progestin therapy than in those assigned to placebo. Observational studies had previously suggested reduced CHD risk in hormone users.